DNLI
Price
$14.00
Change
-$0.53 (-3.65%)
Updated
Jul 18 closing price
Capitalization
2.03B
10 days until earnings call
FTRE
Price
$4.69
Change
-$0.26 (-5.25%)
Updated
Jul 18 closing price
Capitalization
424.63M
16 days until earnings call
Interact to see
Advertisement

DNLI vs FTRE

Header iconDNLI vs FTRE Comparison
Open Charts DNLI vs FTREBanner chart's image
Denali Therapeutics
Price$14.00
Change-$0.53 (-3.65%)
Volume$1.31M
Capitalization2.03B
Fortrea Holdings
Price$4.69
Change-$0.26 (-5.25%)
Volume$1.61M
Capitalization424.63M
DNLI vs FTRE Comparison Chart in %
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. FTRE commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and FTRE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (DNLI: $14.00 vs. FTRE: $4.69)
Brand notoriety: DNLI and FTRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 88% vs. FTRE: 59%
Market capitalization -- DNLI: $2.03B vs. FTRE: $424.63M
DNLI [@Biotechnology] is valued at $2.03B. FTRE’s [@Biotechnology] market capitalization is $424.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileFTRE’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • FTRE’s FA Score: 1 green, 4 red.
According to our system of comparison, FTRE is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 2 TA indicator(s) are bullish while FTRE’s TA Score has 3 bullish TA indicator(s).

  • DNLI’s TA Score: 2 bullish, 6 bearish.
  • FTRE’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, both DNLI and FTRE are a bad buy in the short-term.

Price Growth

DNLI (@Biotechnology) experienced а -3.58% price change this week, while FTRE (@Biotechnology) price change was -8.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.57%. For the same industry, the average monthly price growth was +17.33%, and the average quarterly price growth was +37.94%.

Reported Earning Dates

DNLI is expected to report earnings on Oct 30, 2025.

FTRE is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.03B) has a higher market cap than FTRE($425M). DNLI YTD gains are higher at: -31.305 vs. FTRE (-74.853). DNLI has higher annual earnings (EBITDA): -505.16M vs. FTRE (-552.6M). DNLI has more cash in the bank: 818M vs. FTRE (102M). DNLI has less debt than FTRE: DNLI (48.6M) vs FTRE (1.29B). FTRE has higher revenues than DNLI: FTRE (2.69B) vs DNLI (0).
DNLIFTREDNLI / FTRE
Capitalization2.03B425M479%
EBITDA-505.16M-552.6M91%
Gain YTD-31.305-74.85342%
P/E RatioN/AN/A-
Revenue02.69B-
Total Cash818M102M802%
Total Debt48.6M1.29B4%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIFTRE
RSI
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
65%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
78%
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 5 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSSMX47.520.03
+0.06%
Fidelity Stock Selector Mid Cap
PRVRX12.88-0.01
-0.08%
PGIM Quant Solutions Large-Cap Val R
VFSNX259.27-0.33
-0.13%
Vanguard FTSE All-Wld ex-US SmCp Idx Ins
MLMIX22.83-0.03
-0.13%
Morgan Stanley Instl Global Core I
HGHVX40.27-0.37
-0.91%
Hartford Healthcare R6

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with SYRE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
-5.25%
SYRE - FTRE
42%
Loosely correlated
-3.55%
DNLI - FTRE
42%
Loosely correlated
-3.65%
BHVN - FTRE
41%
Loosely correlated
-7.02%
TECH - FTRE
41%
Loosely correlated
-2.38%
XNCR - FTRE
40%
Loosely correlated
-1.10%
More